Migraine trials in Germany
2 of 3 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Where
- Berlin, Schwerin
- Age
- 18 years to 45 years
- People
- 723 worldwide
- Run by
- Pfizer
See details and how to joinNCT06641466 · EU 2024-517121-10-00 - No phaseTaking peopleMultimodal Physiotherapy Intervention for People With Migraine
- Where
- Osnabrück
- Age
- 18 years to 70 years
- People
- 195
- Run by
- Hochschule Osnabruck
See details and how to joinNCT07671703